GWAYF (Greenway Greenhouse Cannabis) Research & Development: $0.01 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Greenway Greenhouse Cannabis Research & Development?

Greenway Greenhouse Cannabis GWAYF +8.53% Research & Development is $0.01 Mil as of Mar. 2026. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Greenway Greenhouse Cannabis's Research & Development for the three months ended in Mar. 2026 was $0.01 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.01 Mil.

Greenway Greenhouse Cannabis  (OTCPK:GWAYF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Greenway Greenhouse Cannabis Research & Development Related Terms

Greenway Greenhouse Cannabis Research & Development Historical Data

* Premium members only.

The historical data trend for Greenway Greenhouse Cannabis's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Greenway Greenhouse Cannabis Research & Development Chart

Greenway Greenhouse Cannabis Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial 0.04 0.00 0.00 0.05 0.01

Greenway Greenhouse Cannabis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.00 0.00 0.00 0.01

Greenway Greenhouse Cannabis Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.01 Mil mean?
Greenway Greenhouse Cannabis (GWAYF) has a Research & Development of $0.01 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Greenway Greenhouse Cannabis and its competitors.
Is Greenway Greenhouse Cannabis' Research & Development too high?
Greenway Greenhouse Cannabis' current Research & Development is $0.01 Mil.
How does Greenway Greenhouse Cannabis' Research & Development compare to ZTS?
Greenway Greenhouse Cannabis' Research & Development of $0.01 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Greenway Greenhouse Cannabis and its competitors. Greenway Greenhouse Cannabis's current Research & Development is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenway Greenhouse Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Greenway Greenhouse Cannabis (GWAYF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.19, compared to a current price of $0.07 — trading 61.2% below its estimated fair value. The current Research & Development is $0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Greenway Greenhouse Cannabis (GWAYF), the current Research & Development is $0.01 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Greenway Greenhouse Cannabis Business Description

Other Exchanges GWAY:Canada
Address 1478 Seacliff Drive, Kingsville, ON, CAN, N9Y 2M2
Greenway Greenhouse Cannabis Corp is licensed to cultivate, process and sell to ensures harvests always consist of the highest quality cannabis strains with resinous flowers, trichomes, and rich cannabinoid profiles. The Company's nursery facility is located in Kingsville, Ontario, and its flowering and processing facility is located in Leamington, Ontario. The business model is to supply bulk packaged, high quality cannabis to the Canadian, cannabis industry at prices that ultimately provide a value proposition to the consumers. Greenway has three divisions with various locations; Greenway Nursery, Greenway Cultivation and future plans for Greenway Farmgate Retail Store.